Capital Fund Management S.A. Sorrento Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$2.0 - $4.9 $115,824 - $283,768
-57,912 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$4.65 - $7.23 $269,290 - $418,703
57,912 New
57,912 $269,000
Q3 2021

Nov 12, 2021
SELL
$7.41 - $10.99 $2.44 Million - $3.62 Million
-329,434 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$6.35 - $10.0 $2.09 Million - $3.29 Million
329,434 New
329,434 $3.19 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email